Deriv Appoints Rakshit Choudhary As CEO To Lead AI-Driven Strategic Shift

Deriv has appointed Rakshit Choudhary as its new Chief Executive Officer, signaling a leadership evolution that places artificial intelligence at the core of the company’s future growth strategy. Choudhary, a 16-year veteran at Deriv, steps into the role following his tenure as co-CEO, during which he shared responsibilities with Founder Jean-Yves Sireau.

Sireau, who founded Deriv in 1999, will remain involved in a strategic advisory capacity while focusing on his next venture, n1.healthcare, an AI-based company aimed at optimizing personal health through advanced data analysis.

“As I now step into the CEO role, the path ahead looks exciting”

Choudhary commented on LinkedIn, “Deriv has come a long way in the last 25 years, thanks to our amazing team, the leadership of our founder Jean-Yves Sireau, and the continued trust from our clients and partners worldwide. Having joined in 2009 and recently served as co-CEO alongside Jean-Yves, I’ve had the privilege to learn from his experience firsthand and prepare for this transition. I’m grateful for his mentorship and excited that he’ll continue to guide us in his new role.”

He added, “As I now step into the CEO role, the path ahead looks exciting. We have a strong leadership team, clear strategic direction, and a culture that thrives on innovation. We’ll be doubling down on innovation, accelerating growth in core markets, and fully embracing our AI-first strategy.”

Deriv serves over 3 million clients globally and operates in more than 20 offices worldwide. Its trading platform offerings span multiple asset classes, including forex, synthetic indices, cryptocurrencies, commodities, and stock indices. The firm provides both proprietary and third-party platforms such as Deriv MT5, Deriv X, and SmartTrader, supported by automation tools like Deriv Bots and API solutions for algorithmic traders.

The appointment of Choudhary, who has held multiple leadership roles within Deriv’s operations, strategy, and technology units, is aligned with the company’s plans to integrate AI across its infrastructure. The firm is expected to focus on product personalization, predictive analytics, and operational efficiency as it scales.

Under Choudhary’s leadership, Deriv plans to expand its footprint in key markets and deepen its investment in AI technologies. The company has already started reshaping its internal processes and client-facing tools to enhance user experience and decision-making.

This transition marks the first time that Sireau steps back from a hands-on leadership role in Deriv. His new company, n1.healthcare, leverages AI to analyze user data and recommend customized wellness interventions. The move reflects a growing crossover between fintech expertise and the healthtech space, as experienced founders increasingly look to apply technological and data-driven insights across verticals.

With Choudhary now at the helm, Deriv is expected to maintain its focus on global market access and customer-centric innovation while laying the groundwork for AI-native trading experiences.